Terumo Corp - Company Profile
Powered by
All the data and insights you need on Terumo Corp in one report.
- Save hours of research time and resources with
our up-to-date Terumo Corp Strategy Report
- Understand Terumo Corp position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Terumo Corp (Terumo) manufactures and markets medical care products including hospital and medical products and equipment. The company’s major product categories include pharmaceuticals, blood bags, disposable medical devices, nutritional food supplements, cardiovascular systems, vascular grafts, blood glucose monitoring systems, medical electronics, peritoneal dialysis, and digital thermometers. Its systems find applications in therapies performed inside blood vessels and cardiac and vascular surgery. Terumo also operates blood centers for collecting blood and processing it to address the transfusion requirement of patients. The company operates through subsidiaries and associate companies in Europe, North America, South America, Asia Pacific, the Middle East, and Africa. Terumo is headquartered in Shibuya-ku, Tokyo, Japan.
Terumo Corp premium industry data and analytics
Products and Services
Products | Brands |
---|---|
Cardiac and Vascular: | Nobori |
Interventional Systems (TIS): | SurGuard |
Angiographic Guidewires | SurFlash |
XYZ | XYZ |
XYZ | XYZ |
XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
Year | Event | Description |
---|---|---|
2023 | New Products/Services | In December, the company unveiled Ultimaster Nagomi. |
2023 | Corporate Changes/Expansions | In November, the company announced the establishment of Terumo South Africa (Pty) Ltd. |
2023 | Contracts/Agreements | In October, Terumo Blood and Cell Technologies and BioCentriq announced collaboration working to demonstrate the capabilities of Terumo BCT's automated cell and gene therapy platforms to accelerate CAR-T cell development. |
Competitor Comparison
Key Parameters | Terumo Corp | Medtronic Plc | Becton Dickinson and Co | Nipro Corp | Merit Medical Systems Inc |
---|---|---|---|---|---|
Headquarters | Japan | Ireland | United States of America | Japan | United States of America |
City | Shibuya-Ku | Dublin | Franklin Lakes | Settsu-Shi | South Jordan |
State/Province | Tokyo | - | New Jersey | Osaka | Utah |
No. of Employees | 30,207 | 95,000 | 73,000 | 38,770 | 6,950 |
Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Toshiaki Takagi | Chairman | Executive Board | 2022 | - |
Kyo Nishikawa | Director; Managing Executive Officer; Chief Human Resources Officer | Executive Board | 2021 | - |
Hikaru Samejima | Director; Chief Executive Officer | Executive Board | 2024 | - |
Norimasa Kunimoto | Director; Group Managing Executive Officer | Executive Board | 2024 | - |
Toshihiko Osada | Director; Group Senior Managing Executive Officer | Executive Board | 2024 | - |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer